Human medicines European public assessment report EPAR Abseamed epoetin alfa AnemiaKidney Failure ChronicCancer Date of authorisation 27082007 Date of refusal 18062009 Revision 21 Status Authorised

Human medicines European public assessment report (EPAR): Abseamed, epoetin alfa, Anemia,Kidney Failure, Chronic,Cancer, Date of authorisation: 27/08/2007, Date of refusal: 18/06/2009, Revision: 21, Status: Authorised

11:04 EDT 19 Mar 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Abseamed, epoetin alfa, Anemia,Kidney Failure, Chronic,Cancer, Date of authorisation: 27/08/2007, Date of refusal: 18/06/2009, Revision: 21, Status: Authorised

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Abseamed, epoetin alfa, Anemia,Kidney Failure, Chronic,Cancer, Date of authorisation: 27/08/2007, Date of refusal: 18/06/2009, Revision: 21, Status: Authorised"